Seizert Capital Partners LLC boosted its holdings in shares of Utah Medical Products, Inc. (NASDAQ:UTMD – Free Report) by 58.3% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The firm owned 5,736 shares of the medical instruments supplier’s stock after buying an additional 2,112 shares during the period. Seizert Capital Partners LLC owned approximately 0.16% of Utah Medical Products worth $384,000 as of its most recent SEC filing.
Several other large investors also recently added to or reduced their stakes in the business. Copeland Capital Management LLC purchased a new stake in Utah Medical Products during the third quarter valued at about $53,000. Allspring Global Investments Holdings LLC purchased a new stake in Utah Medical Products during the second quarter valued at about $83,000. Victory Capital Management Inc. raised its position in Utah Medical Products by 124.4% during the second quarter. Victory Capital Management Inc. now owns 2,673 shares of the medical instruments supplier’s stock valued at $179,000 after purchasing an additional 1,482 shares in the last quarter. EntryPoint Capital LLC raised its position in Utah Medical Products by 124.1% during the first quarter. EntryPoint Capital LLC now owns 3,240 shares of the medical instruments supplier’s stock valued at $230,000 after purchasing an additional 1,794 shares in the last quarter. Finally, GSA Capital Partners LLP purchased a new stake in Utah Medical Products during the third quarter valued at about $231,000. Institutional investors own 69.60% of the company’s stock.
Wall Street Analysts Forecast Growth
Separately, StockNews.com downgraded Utah Medical Products from a “strong-buy” rating to a “buy” rating in a research report on Thursday, November 7th.
Utah Medical Products Trading Down 0.7 %
UTMD opened at $66.05 on Monday. The company has a market cap of $223.91 million, a P/E ratio of 15.47 and a beta of 0.08. The business’s 50-day moving average price is $66.03 and its 200-day moving average price is $67.34. Utah Medical Products, Inc. has a 12 month low of $63.38 and a 12 month high of $87.21.
Utah Medical Products Increases Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 3rd. Stockholders of record on Monday, December 16th will be issued a $0.305 dividend. The ex-dividend date of this dividend is Monday, December 16th. This represents a $1.22 annualized dividend and a dividend yield of 1.85%. This is an increase from Utah Medical Products’s previous quarterly dividend of $0.30. Utah Medical Products’s payout ratio is currently 28.10%.
Utah Medical Products Profile
Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.
See Also
- Five stocks we like better than Utah Medical Products
- Golden Cross Stocks: Pattern, Examples and Charts
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- How to Find Undervalued Stocks
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Want to see what other hedge funds are holding UTMD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Utah Medical Products, Inc. (NASDAQ:UTMD – Free Report).
Receive News & Ratings for Utah Medical Products Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Utah Medical Products and related companies with MarketBeat.com's FREE daily email newsletter.